Atlas Trials

The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

Clinical trial NCT04659239 · UNKNOWN

Trial details

NCT number
NCT04659239
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2021-01-28
Primary completion
2021-09-01
Enrollment
34020

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.